xCures facilitates expanded access to OKN-007

This expanded access protocol is intended to provide compassionate use of OKN-007 for participants with diffuse midline glioma (including diffuse intrinsic pontine glioma, DIPG) who have completed standard-of-care radiation therapy.

If you or your doctor believes your child or dependent may be eligible to enroll, please register for the XCELSIOR platform trial. Registration takes about 5 minutes to complete.

Once you do so, the xCures team will coordinate enrollment in the expanded access protocol and/or offer alternative treatment assistance, as appropriate.

Once we have received your registration, your child or dependent will be enrolled in our cancer patient data registry, through which we will collect and review medical information and help track your safety and efficacy outcomes.

Register Now
Register Now